Nanotechnology in cancer therapy
Year: 2013
Type: review
Abstract: Cancer is one of the major causes of mortality worldwide and advanced techniques for therapy are urgently needed. The development of novel nanomaterials and nanocarriers has allowed a major drive to improve drug delivery in cancer. The major aim of most nanocarrier applications has been to protect the drug from rapid degradation after systemic delivery and allowing it to reach tumor site at therapeutic concentrations, meanwhile avoiding drug delivery to normal sites as much as possible to reduce adverse effects. These nanocarriers are formulated to deliver drugs either by passive targeting, taking advantage of leaky tumor vasculature or by active targeting using ligands that increase tumoral uptake potentially resulting in enhanced antitumor efficacy, thus achieving a net improvement in therapeutic index. The rational design of nanoparticles plays a critical role since structural and physical characteristics, such as size, charge, shape, and surface characteristics determine the biodistribution, pharmacokinetics, internalization and safety of the drugs. In this review, we focus on several novel and improved strategies in nanocarrier design for cancer therapy.
Source: Journal of drug targeting
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
Awards: Subcellular localization of nanoparticles, Texas Center for Cancer Nanomedicine, (PQD3) The role and therapeutic potential of ZNF304 in Ovarian Cancer, G3441323258, Novel Therapeutics for Translation Control in Breast Cancer, UPR/MDACC: Partnership for Excellence in Cancer Research (1 of 2), Novel extra cellular RNA-based combinatorial RNA inhibition therapy, New Reagents for Synthesis of High Potency siRNA, The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer, Nanoparticle-Directed Photothermal Ablation of Primary Brain Tumors guided by Mag, Cancer Center Support Grant, The University of Texas M. D. Anderson Cancer Center SPORE in Melanoma
OpenAlex ID: W2077803783
